Developmental lead exposure impairs anxiolytic-like effects of diazepam and 8-OH-DPAT in male wistar rats

Polish Journal of Environmental Studies

Volumn 17, Issue 5, 2008, Pages 751-756

  Nowak, P ^a   Kostrzewa, R M ^b   Adamus Sitkiewicz, B ^a   Brus, R ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b East Tennessee State University   (United States)

Author keywords

Anxiety; Exposure; Lead; Prenatal; Rats

Indexed keywords

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 55449129607     PISSN: 12301485     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. DEVOTO P., FLORE G., IBBA A., FRATTA W., PANI L. Lead intoxication during intrauterine life and lactation but not during adulthood reduces nucleus accumbens dopamine release as studied by brain microdialysis. Toxicol. Lett. 121, 199, 2001.
2. MARCHETTI C. Molecular targets of lead in brain neurotoxicity. Neurotox. Res. 5, 221, 2003.
3. DEVI C.B., REDDY G.H., PRASANTHI R.P., CHETTY C.S., REDDY G.R. Developmental lead exposure alters mitochondrial monoamine oxidase and synaptosomal catecholamine levels in rat brain. Int. J. Dev. Neurosci. 23, 375, 2005.
4. BRUS R., SZKILNIK R., NOWAK P., KONECKI J., GLOWACKA M., KASPERSKA A., OŚWIECIMSKA J., SAWCZUK K., SHANI J. Prenatal exposure of rats to lead, induce changes in the reactivity of the central dopaminergic, serotoninergic and muscarinic receptors, but not in glucose uptake in their offspring. Pharmacol. Rev. Comm. 9, 299, 1999.
5. BRUS R., SZKILNIK R., NOWAK P., OŚWIECIMSKA J., KASPERSKA A., SAWCZUK K., SŁOTA P., KWIECIŃSKI A., KUBAŃSKI N., SHANI J. Effect of lead and ethanol, consumed by pregnant rats, on behavior of their grown offsprings. Pharmacol. Rev. Comm. 10, 175, 1999.
6. SZKILNIK R., NOWAK P., WINIARSKA H., DURCZOKA., MALECKI S., RYCERSKA A., BRUS R., SHANI J. Effect of zinc on the reactivity of the central dopamine receptors in rats, prenatally exposed to lead. Pharmacol. Rev. Comm. 11, 319, 2001.
7. SZCZERBAK G., NOWAK P., KOSTRZEWA R.M., BRUS R. Maternal lead exposure produces long-term enhancement of dopaminergic reactivity in rat offspring. Neurochem. Res. 32, 1791, 2007.
8. DURCZOK A., SZKILNIK R., BRUS R., NOWAK P., LABUS L., KONECKI J., DRABEK K., KUBALLA G., RYCERSKI W., MENGEL K. Effect of organic mercury exposure during early stage of ontogenic development on the central dopaminergic system in adult rats. Pol. J. Environ. Stud. 11, 307, 2002.
9. KISZKA W., SZKILNIK R., BRUS R., NOWAK P., KONECKI J., DURCZOK A., MENGEL K., SHANI J. Prenatal exposure of rats to mercury induces changes in central dopaminergic activity and in glucose uptake by their offspring. Pharmacol. Rev. Comm. 12, 77, 2002.
10. NOWAK P., BRUS R., SZKILNIK R., LABUS L., WINIARSKA H., SHANI J. Exposure of pregnant rats to ethanol and cadmium modulates levels of biogenic amines in brains of their adult offspring. Pharmacol. Rev. Comm. 12, 229, 2002.
11. NOWAK P., DABROWSKA J., BORTEL A., BIEDKA I., KOSTRZEWA R.M., BRUS R. Prenatal cadmium and ethanol increase amphetamine-evoked dopamine release in rat striatum. Neurotoxicol. Teratol. 28, 563, 2006.
12. REDDY G.R., DEVI B.C., CHETTY C.S. Developmental lead neurotoxicity: alterations in brain cholinergic system. Neurotoxicology 28, 402, 2007.
13. VIRGOLINI M.B., CANCELA L.M., FULGINITI S. Behavioral responses to ethanol in rats perinatally exposed to low lead levels. Neurotoxicol. Teratol. 21, 551, 1999.
14. MOREIRA E.G., VASSILIEFF I., VASSILIEFF V.S. Developmental lead exposure: behavioral alterations in the short and long term. Neurotoxicol. Teratol. 23, 489, 2001.
15. JAAKO-MOVITS K., ZHARKOVSKYT, ROMANTCHIK O., JURGENSON M., MERISALU E., HEIDMETS L.T., ZHARKOVSKY A. Developmental lead exposure impairs contextual fear conditioning and reduces adult hippocampal neurogenesis in the rat brain. Int. J. Dev. Neurosci. 23, 627, 2005.
16. EISENBERG R., DAVIS S.L., ETTNER S., APPEL S., WILKEY S., VAN ROMPAY M., KESSLER R.C. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. J. Am. Med. Assoc. 280, 1569, 1998.
17. WHITING P.J. GABA-A receptors: a viable target for novel anxiolytics? Curr. Opin. Pharmacol. 6, 24, 2006.
18. GREEN A. Neuropharmacology of 5-hydroxytryptamine. Br. J Pharmacol. 147, 145, 2006.
19. NODA M., HIGASHIDA H., AOKI S., WADA K. Multiple signal transduction pathways mediated by 5-HT receptors, Mol. Neurobiol. 29, 31, 2004.
20. LANFUMEY L., HAMON M. 5-HT1 receptors. Curr. Drug Targets CNS Neurol. Disord. 3, 1, 2004.
21. BREMNER J.D., INNIS R.B., SOUTHWICK S.M., STAIB L., ZOGHBI S., CHARNEY D.S. Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am. J. Psychiatry 157, 1120, 2000.
22. NEUMEISTER A., YOUNG T., STASTNY J. Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter. Psychopharmacology (Berl). 174, 512, 2004.
23. PELLOW S., CHOPIN P., FILE S.E., BRILEY M. Validation of open:closed arm entries in an elevated plusmaze as a measure of anxiety in the rat. J. Neurosci. Methods. 14, 149, 1985.
24. VOGEL J.R., BEER B., CLODY D.E. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacology, Berlin, 21, 1, 1971.
25. LECHIN F., VAN DER DIJS B., HERNÁNDEZ-ADRIÁN G. Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: relevance for neuropharmacological therapy. Prog. Neuropsychopharmacol. Biol. Psychiatry 30, 565, 2006.
26. MILLAN M.J. The neurobiology and control of anxious states. Prog. Neurobiol. 70, 83, 2003.
27. WADA T., FUKUDA N. Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze. Psychopharmacology, Berlin, 104, 444, 1991.
28. PRZEGALIŃSKI E., TATARCZYŃSKA E., CHOJNACKAWÓJCIK E. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats. Neuropharmacology 39, 1858, 2000.
29. NAITO H., NAKAMURA A., INOUE M., SUZUKI Y. Effect of anxiolytic drugs on air-puff-elicited ultrasonic vocalization in adult rats. Exp. Anim. 52, 409, 2003.
30. GRAEFF F.G., NETTO C.F., ZANGROSSI H. The elevated T-maze as an experimental model of anxiety. Neurosci. Biobehav. Rev. 23, 237, 1998.
31. 2+ impairs GABAergic synaptic transmission in rat hippocampal slices: a possible involvement of presynaptic calcium channels. Brain Res. 1088, 93, 2006.
32. BRAGA M.F., PEREIRA E.F., MARCHIORO M., ALBUQUERQUE E.X. Lead increases tetrodotoxin-insensitive spontaneous release of glutamate and GABA from hippocampal neurons. Brain Res. 826, 10, 1999.